Early Human Development
Volume 82, Issue 2 , Pages 97-103 , February 2006

Retrospective economic evaluation of a controlled trial of indomethacin prophylaxis for patent ductus arteriosus in premature infants

  • John A.F. Zupancic

      Affiliations

    • Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
    • Harvard Medical School, Boston, Massachusetts, United States
    • Corresponding Author InformationCorresponding author. Department of Neonatology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Rose Building Room 318, Boston, MA 02215, United States. Tel.: +1 617 667 3276; fax: +1 617 667 7040.
    • ,
  • Douglas K. Richardson

      Affiliations

    • Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
    • Harvard Medical School, Boston, Massachusetts, United States
    • Deceased.
    • ,
  • Bernie J. O'Brien

      Affiliations

    • Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    • Deceased.
    • ,
  • Catherine G. Cronin

      Affiliations

    • Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, Canada
    • ,
  • Barbara Schmidt

      Affiliations

    • Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    • Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada
    • ,
  • Robin Roberts

      Affiliations

    • Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    • ,
  • Milton C. Weinstein

      Affiliations

    • Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, United States
    • ,
  • Trial of Indomethacin Prophylaxis in Preterms Investigators

References 

  1. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med. 2001;344(26):1966–1972
  2. Bayley N. Manual for the Bayley scales of infant development. 2nd ed.. San Antonio, Texas: Psychological Corporation; 1993;
  3. Briggs AH, O'Brien BJ. The death of cost-minimization analysis?. Health Econ. 2001;10(2):179–184
  4. Zupancic JA, Richardson DK, O'Brien BJ, Schmidt B, Weinstein MC. Daily cost prediction model in neonatal intensive care. Int J Technol Assess Health Care. 2003;19(2):330–338
  5. Zupancic JA, Richardson DK. Characterization of neonatal personnel time inputs and prediction from clinical variables—a time and motion study. J Perinatol. 2002;22(8):658–663
  6. British Columbia Ministry of Health Medical Services Commission . Payment schedule. 1999;
  7. Canadian Coordinating Office for Health Technology Assessment . A guidance document for the costing process. Version 1.0 ed.. Ottawa: Canadian Coordinating Office for Health Technology Assessment; 1996;
  8. CANSIM . In: Consumer price indexes for Canada, annual, 1996 classification (matrix 9957). Statistics Canada; 1999;
  9. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman and Hall/CRC; 1993;
  10. Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves—facts, fallacies and frequently asked questions. Health Econ. 2004;13(5):405–415
  11. O'Brien B, Drummond MF, Labelle RJ, Willan A. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care. Med Care. 1994;32(2):150–163
  12. Moya MP, Goldberg RN. Cost-effectiveness of prophylactic indomethacin in very-low-birth-weight infants. Ann Pharmacother. 2002;36(2):218–224
  13. Ventura SJ, Martin JA, Curtin SC, Matthews TJ. (National Center for Health Statistics). Report of final natality statistics, 1996. Mon Vital Sta Rep. 1998;46(11 Supplement):1–100
  14. Health Statistics Division. Births and Deaths, 1995. Ottawa: Statistics Canada; 1995 May, 1997. Report No.: 84-210-XIB.
  15. Ellison RC, Peckham GJ, Lang P, Talner NS, Lerer TJ, Lin L, et al. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics. 1983;71(3):364–372
  16. Drummond MF, Bloom BS, Carrin G, Hillman AL, Hutchings HC, Knill-Jones RP, et al. Issues in the cross-national assessment of health technology. Int J Technol Assess Health Care. 1992;8(4):671–682
  17. Schulman K, Burke J, Drummond M, Davies L, Carlsson P, Gruger J, et al. Resource costing for multinational neurologic clinical trials: methods and results. Health Econ. 1998;7(7):629–638
  18. Freemantle N, Drummond M. Should clinical trials with concurrent economic analyses be blinded?. J Am Med Assoc. 1997;277(1):63–64

PII: S0378-3782(06)00014-4

doi: 10.1016/j.earlhumdev.2006.01.004

Early Human Development
Volume 82, Issue 2 , Pages 97-103 , February 2006

Article Tools

* Image Usage & Resolution